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Introduction
Diabetes mellitus is a metabolic disorder of multiple 
 etiology characterized by chronic hyperglycemia with a 
disturbance of carbohydrate, fat, and protein metabolism 
resulting from defects in insulin secretion, insulin action, 
or both (WHO, 1999). Recent studies suggest that post-
prandial hyperglycemia could induce  non-enzymatic 
glycosylation of various proteins, resulting in the devel-
opment of chronic complications such as micro- and 
macrovascular diseases (Baron, 1998), and has been pro-
posed as an independent risk factor for cardiovascular 
disease (Ceriello, 1998). Therefore, control of postpran-
dial plasma glucose levels is critical in the early treat-
ment of diabetes mellitus (Shim et al., 2003). This can be 
done by retarding the absorption of glucose through the 
inhibition of carbohydrate hydrolyzing enzymes such as 
α-amylase, α-glucosidase, β-glucosidase, and sucrase, 
in the digestive tract. Inhibitors of these enzymes delay 
carbohydrate digestion and prolong overall carbohy-
drate digestion time, causing a reduction in the rate of 
glucose absorption and, consequently, blunting post-
prandial hyperglycemia (Rhabasa-Lhoret & Chiasson, 
2004). Several α-glucosidase inhibitors have recently 
been developed from natural sources (Asano et al., 
2001; Hiroyuki et al., 2001; Lee & Lee, 2001; Matsui et al., 
2001). Examples of such inhibitors that are in clinical 
use are acarbose, miglitol, and voglibose (Bailey, 2003). 
In the present investigation, Ficus racemosa stem bark 
(FRB), a proven hypoglycemic agent (Rao et al., 2002; 
Vasudevan et al., 2007) being used by various cultures 
across India since ancient times for the treatment of dia-
betes (Anonymous, 1952), was studied for its ability to 
inhibit carbohydrate hydrolyzing enzymes using in vitro 
model systems. Further, the effect of heat treatment on 
the enzyme inhibitory activities was also studied.
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Abstract
Herbal medicines have been used since prehistoric times by different cultures worldwide for the treat-
ment of diabetes. The present investigation evaluated the effect of Ficus racemosa Linn. (Moraceae) stem 
bark on carbohydrate hydrolyzing enzymes, viz., porcine pancreatic α-amylase, rat intestinal α-glucosidase, 
sucrase, and almond β-glucosidase, using in vitro model systems. In addition, the effect of heat treat-
ment was also studied. Untreated F. racemosa bark (FRB) significantly inhibited (p ≤ 0.05) α-amylase, 
α-glucosidase, β-glucosidase, and sucrase in a dose-dependent manner. Heat treatment of the sample 
comparably increased α-amylase, α-glucosidase, and sucrase inhibitory activities, while a marginal decrease 
in β-glucosidase inhibitory activity was observed; however, no statistical differences were noted. Untreated 
FRB showed IC50 values of 0.94% and 280, 212, and 367 μg/mL for α-amylase, α-glucosidase, β-glucosidase, 
and sucrase, respectively, while the IC50 values for heat treated FRB were 0.58% and 259, 223, and 239 μg/
mL, respectively. Further, a significant correlation (p ≤ 0.01; r = 0.791) was observed between α-amylase, 
α-glucosidase, β-glucosidase, and sucrase inhibitory activities of both untreated and heat treated FRB. 
The results clearly demonstrate that inhibition of carbohydrate hydrolyzing enzymes is one mechanism 
through which F. racemosa stem bark exerts its hypoglycemic effect in vivo. Therefore, the potential exists 
to explore the utilization of F. racemosa stem bark in the development of nutraceuticals and functional 
foods for the management of diabetes and related symptoms/disorders.
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Materials and methods
Chemicals and reagents
p-Nitrophenyl-α-d-glucopyranoside, p-nitrophenyl-β-
d-glucopyranoside, β-glucosidase from almonds, and 
3,5-dinitrosalisylic acid were purchased from Sisco 
Research Laboratory, India. A glucose oxidase/peroxi-
dase assay kit was purchased from Aggappe Diagnostics, 
India. α-Amylase (23 u/mg solid) was purchased from 
Sigma Aldrich, India. All the chemicals and reagents 
used in the study were of extra pure analytical grade.
Collection of plant material
Ficus racemosa stem bark was collected from 
Mukkadahally, Chamarajanagar district of Karnataka, 
India during September 2007, and was subsequently iden-
tified by Dr. Shivprasad Hudeda, JSS Ayurvedic Medical 
College, Mysore; a voucher specimen (BOT-001/2008) 
was deposited at the herbarium of the Department of 
Studies in Botany, University of Mysore, Mysore, India. 
The bark was cut into small pieces, dried (50°C) and pow-
dered, passed through a 60 mesh sieve (BS), and stored 
in an airtight container at 4°C till further use.
Heat treatment
The bark powder was subjected to heat treatment in a 
vacuum oven at 100°C for 60 min, cooled in a desiccator, 
and used for the preparation of emulsion.
Preparation of the sample emulsion
Amounts of 100 mg of both untreated and heat treated 
FRB were triturated with two drops of Tween 20 in a glass 
mortar and pestle and emulsified with maleate buffer 
(0.1 M, pH 6.0). The volume was made up to 10 mL using 
a volumetric flask so as to obtain an emulsion contain-
ing 10 mg of the sample/mL of emulsion.
Preparation of crude enzyme solution of α-glucosidase 
and sucrase from rat intestinal brush border
The crude enzyme solution containing α-glucosidase 
and sucrase was prepared by slight modification of the 
procedure of Dahlqvist (1964). Male healthy rats of Wistar 
strain maintained on standard laboratory chow, weigh-
ing 140–160 g, were obtained from the Central Animal 
House, Department of Zoology, University of Mysore. 
The rats were fasted overnight, sacrificed by cervical dis-
location, and the small intestines immediately excised. 
The intestines were washed with ice-cold maleate buffer 
and the brush border was carefully removed using glass 
slides and homogenized with maleate buffer (1:5, w/v) 
in ice-cold condition. The homogenate was then centri-
fuged (10,000 g; 15 min) at 4°C. The supernatant was col-
lected and used as a crude source of α-glucosidase and 
sucrase. All animal procedures were approved by the 
Animal Ethical Committee of the University of Mysore 
in accordance with animal experimentation and care.
Assay of α-amylase inhibitory activity
The effect of FRB on α-amylase activity was studied using 
an enzyme–starch system (Ou et al., 2001). FRB (1–5%) 
was mixed by stirring with 25 mL of 4% potato starch in 
a beaker; 100 mg of α-amylase was added to the starch 
solution, stirred vigorously, and incubated at 37°C for 
60 min. After the incubation period, 0.1M NaOH was 
added to terminate enzyme activity. The mixture was 
centrifuged (3000 g; 15 min) and the glucose content in 
the supernatant was determined.
Assay of α-glucosidase inhibitory activity
α-Glucosidase inhibitory activity was assayed accord-
ing to the method of Honda and Hara (1993). Enzyme 
solution (10 µL) and varying concentrations of sam-
ple emulsion (10–50 µL) were incubated together for 
10 min at 37°C and the volume was made up to 210 µL 
with maleate buffer, pH 6.0. The enzyme reaction was 
started by adding 200 µL of 2 mM p-nitrophenyl-α-d-
glucopyranoside solution and further incubated at 37°C 
for 30 min. The reaction was terminated by treating the 
mixture in a boiling water bath for 5 min. After the addi-
tion of 1.0 mL of 0.1 M disodium hydrogen phosphate 
solution, absorption of the liberated p-nitrophenol was 
read at 400 nm.
Assay of β-glucosidase inhibitory activity
Various concentrations of sample emulsion (10–50 μL) 
were pre-incubated with β-glucosidase (5 μL; 380 U/mL) 
and the volume was made up to 210 μL with phosphate 
buffer (10 mM; pH 7.0). The enzyme reaction was started 
by adding 200 µL of p-nitrophenyl-β-d-glucopyranoside 
solution (10 mM) and the mixture incubated (37°C, 
30 min). After incubation, distilled water (850 μL) was 
added, the solution heated at 100°C for 3 min to stop 
the reaction, and the absorbance of the solution read at 
440 nm (Kawai et al., 2006).
Assay of sucrase inhibitory activity
The effect of the FRB on sucrase activity was assayed 
according to the method of Honda and Hara (1993). The 
enzyme solution (10 µL) and varying concentrations of 
sample emulsion (10–50 µL) were incubated together for 
10 min at 37°C and the volume was made up to 200 µL 
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with maleate buffer (pH 6.0). The enzyme reaction was 
started by adding 100 µL sucrose solution (60 mM). After 
30 min, the reaction was terminated by adding 200 µL of 
3,5-dinitrosalicylic acid reagent and treating the mixture 
in a boiling water bath for 5 min. The absorbance of the 
solution was read at 540 nm.
The percent inhibitory activities were calculated 
using the following formula:
% = −
×
 Inhibition
100
Abs control Abs sample Abs control( )
where Abs control is the absorbance of the control reac-
tion (containing all reagents except the test sample), 
and Abs sample is the absorbance of the test sample. An 
untreated enzyme solution was used as the control. All 
experiments were carried out in triplicate.
Statistical analysis
The data were analyzed by analysis of variance (ANOVA) 
followed by Tukey’s multiple comparisons test for signifi-
cant differences using SPSS 14.0 computer software. The 
values were considered significant when p ≤ 0.05. IC
50
 
values were calculated by Boltzmann’s dose–response 
analysis using Origin 6.1 software.
Results
Effect of FRB on α-amylase activity
The α-amylase inhibitory activity of FRB was studied 
using the α-amylase–starch model system and the 
results are presented in Figure 1a. α-Amylase inhibitory 
activity of untreated FRB ranged 50–86% and 56–89% 
for heat treated FRB. Both untreated and heat treated 
FRB showed dose-dependent inhibition of the enzyme. 
It was observed that although heat treatment increased 
the α-amylase inhibitory activity and decreased the IC
50
 
value, this did not reach statistical significance.
Effect of FRB on α-glucosidase and β-glucosidase 
activity
Both the untreated and heat treated FRB significantly 
inhibited (p ≤ 0.01) α-glucosidase in a dose-dependent 
manner (Figure 1b). The inhibitory activities ranged 
22–67% and 31–73%, respectively, for untreated and heat 
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Figure 1. Effect of Ficus racemosa b﻿ark on (a) α-amylase, (b﻿) α-glucosidase, (c) β-glucosidase, and (d) sucrase activity.
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treated FRB. An IC
50
 value of 280 µg/mL was observed 
for untreated FRB, while a comparably low value of 259 
µg/mL was observed for heat treated FRB. However, 
the difference was statistically insignificant. Similarly, 
β-glucosidase was inhibited by both untreated and heat 
treated FRB in a dose-dependent manner (Figure 1c) and 
their inhibitory activities ranged 29–89% and 27–87%, 
respectively. It is noteworthy here that although heat 
treatment lead to an increase in α-glucosidase inhibi-
tory activity, a marginal decrease in the β-glucosidase 
inhibitory activity was observed in heat treated FRB. 
However, this did not reach statistical significance. The 
IC
50
 values for β-glucosidase inhibitory activities were 
212 µg/mL and 223 µg/mL, respectively, for untreated 
and heat treated FRB.
Effect of FRB on sucrase activity
The effect of FRB on sucrase activity is shown in 
Figure 1d. The sucrase inhibitory activity ranged 12–60% 
and 15–83% for untreated and heat treated FRB, respec-
tively. A dose-dependent inhibition of rat intestinal 
sucrase was observed in both untreated and heat treated 
FRB. However, heat treatment resulted in a significant 
increase (p ≤ 0.05) in the sucrase inhibitory activity of 
the sample, and the IC
50
 value for heat treated FRB was 
significantly lower (p ≤ 0.05) than that of untreated FRB 
(Table 1).
A significant correlation (p ≤ 0.01; r = 0.791) 
was observed between α-amylase, α-glucosidase, 
β-glucosidase, and sucrase inhibitory activities of both 
untreated and heat treated FRB, and the enzyme inhibi-
tory activities of F. racemosa bark were directly propor-
tional to the sample concentration.
Discussion
The development of antidiabetic drugs with comple-
mentary mechanisms of action appears more and 
more necessary in order to achieve durable glycemic 
control in type 2 diabetes by inhibiting in a reversible 
way the hydrolysis of disaccharides and the ultimate 
steps of the digestion of dietary polysaccharides, to 
reduce the postprandial blood glucose increase in dia-
betics (Blickle et al., 2008). The present study evaluated 
the effect of F. racemosa stem bark on glycohydrolase 
enzymes, viz., α-amylase, α-glucosidase, β-glucosidase, 
and sucrase.
Several mechanisms have been proposed for 
the hypoglycemic effect of phytochemicals, such as 
inhibition of carbohydrate metabolizing enzymes, 
manipulation of glucose transporters, β-cell regen-
eration, and enhancement of insulin releasing activity 
(Tiwari & Rao, 2002). In the present investigation, both 
untreated and heat treated FRB effectively inhibited 
porcine pancreatic α-amylase. Generally, inhibition 
of α-amylase activity by medicinal plants is attributed 
to several possible factors such as fiber concentra-
tion, presence of inhibitors on fibers, encapsulation of 
starch and enzyme by the fibers present in the sample 
thereby reducing accessibility of starch to the enzyme, 
and direct adsorption of the enzyme on fibers lead-
ing to decreased amylase activity (Ou et al., 2001). 
However, inhibition of α-amylase activity by FRB could 
be conclusively attributed to the presence of lupeol, a 
triterpenoid (Rahman et al., 1994) reported to inhibit 
α-amylase (Ali et al., 2006).
Glucosidases are crucial in many biological proc-
esses including breakdown of edible carbohydrates 
(Marshall, 1974), and are also involved in a variety 
of metabolic disorders such as diabetes (Robinson 
et al., 1991). Thus, potent and selective glucosidase 
inhibitors have many interesting potential applica-
tions, especially in diabetes (Robinson et al., 1991). 
α-Glucosidase is one among a number of glucosidases 
located in the brush-border surface membrane of 
intestinal cells, and is a key enzyme of carbohydrate 
digestion (Caspary, 1978). α-Glucosidase inhibitors 
block the actions of the enzyme in the small intestine, 
which is rate-limiting in the conversion of oligosac-
charides and disaccharides to monosaccharides, nec-
essary for gastrointestinal absorption. Postprandial 
glucose peaks may be attenuated by delayed glucose 
absorption. The increase in α-glucosidase by heat 
treatment may be due to possible inactivation of the 
phytoconstituents that hinder/decrease the inhibi-
tion of glucosidases. The main benefits attributable to 
α-glucosidase inhibitors are reductions in both post-
prandial glycemic levels and the total range of post-
prandial glucose levels (Lebovitz, 1997).
The inhibition of α-glucosidase by F. racemosa bark 
can be attributed to the presence of tannins, kaemp-
ferol, rutin, bergapten, psoralenes, flavonoids, ficusin, 
coumarin, phenolic glycosides (Baruah & Gohain, 
1992), bergenin, and racemosic acid (Li et al., 2004) 
that are reported to act as strong antioxidant and anti-
inflammatory agents (Khan & Sultana, 2005); reports 
Table 1. IC
50
 values of untreated and heat treated Ficus racemosa b﻿ark (FRB) for different enzymes.
Sample α-Amylase (%) α-Glucosidase (µg/mL) β-Glucosidase (µg/mL) Sucrase (µg/mL)
Untreated FRB 0.94 ± 0.15 280 ± 12.1 212 ± 12.1 367 ± 15.2
Heat treated FRB 0.58 ± 0.15 259 ± 15.6 223 ± 11.7 239 ± 14.3
Note. Values are mean ± SD of triplicate determinations.
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indicate that phenolic-enriched extracts of Solanum 
melongena with moderate free radical scavenging linked 
antioxidant activity have high α-glucosidase inhibitory 
activity. Inhibition of this enzyme provides a strong 
biochemical basis for the management of type 2 dia-
betes by controlling glucose absorption. This phenolic 
 antioxidant-enriched dietary strategy also has the poten-
tial to reduce hyperglycemia-induced pathogenesis 
linked to cellular oxidation stress. These results provide 
a strong rationale for further animal and clinical studies 
(Kwon et al., 2008). The inhibition of β-glucosidase activ-
ity may be exclusively due to the presence of tannins, as 
reports indicate tannins to be effective and exclusive 
inhibitors of glycohydrolase enzymes including α- and 
β-glucosidases (Harnett et al., 2005).
Rat intestinal sucrase occurs as a complex of sucrase 
and isomaltase, which converts sucrose into glu-
cose (Hauri et al., 1982). The inhibition of sucrase by 
F.  racemosa bark may also be due to its phenolic com-
pounds. The increase in sucrase inhibitory activity of 
F. racemosa by heat treatment could be due to the pos-
sible inactivation of the antagonists of sucrase inhibitory 
activity of the sample. Further, the correlation observed 
between α-amylase, α-glucosidase, β-glucosidase, and 
sucrase inhibitory activities of both untreated and heat 
treated FRB represents a parallel and effective inhibition 
of most of the carbohydrate hydrolyzing enzymes in the 
digestive tract.
Conclusion
The results of the present study support the usage of F. 
racemosa bark in traditional medicine for the manage-
ment of diabetes, and emphasize that inhibition of 
carbohydrate hydrolyzing enzymes such as α-amylase, 
α-glucosidase, β-glucosidase, and sucrase is one mecha-
nism through which F. racemosa bark exerts its hypogly-
cemic effect in vivo. Furthermore, since heat treatment 
increases the inhibitory activity of F. racemosa bark, it 
could be used in the formulation of functional foods/
nutraceuticals for the effective management of diabetes.
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